Telemedicine facilitates recovery in ischemic heart disease patients, highlighting improved monitoring and adherence.
The critical role of telemedicine was particularly highlighted during the COVID-19 pandemic, when the number of patients utilizing remote healthcare services increased substantially. In the context of cardiovascular disease, telemedicine has been effectively employed for arrhythmia detection, remote monitoring of patients with heart failure and hypertension, as well as for the follow-up of patients with ischemic heart disease. Telemedicine interventions offer continuous patient monitoring through a range of modalities, including structured telephone or video consultations and remote data transmission from wearable or implantable devices. These strategies support risk factor modification, improve medication adherence, and facilitate symptom surveillance in both coronary artery disease and heart failure. By leveraging phone calls, text messaging, and digital health platforms, clinicians can track vital signs and laboratory parameters, adjust treatment regimens in a timely manner, and promote adherence to physical activity, dietary recommendations, and therapeutic interventions. Consequently, telemedicine has become a reliable and scalable alternative to traditional home-based recovery for a wide range of cardiovascular patients.
No takes yet. Share an insight, caveat, or question.
Pop et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: